Hair restoration treatments prescribed by licensed providers, including FDA-approved medications such as minoxidil and finasteride alongside compounded and peptide options that are not FDA-approved.

Evaluation
Typical evaluation period
Identifying the root cause is the first step toward effective treatment.
The most common cause — genetic sensitivity to DHT affecting follicle miniaturization over time.
Thyroid disorders, menopause, PCOS, and testosterone imbalances can all contribute to hair thinning.
Low iron, biotin, zinc, and vitamin D are common contributors to accelerated hair loss.
Physical or emotional stress can push hair follicles into a resting phase, causing diffuse shedding.
Your provider will recommend the most appropriate combination based on your hair loss pattern and health profile.
A 5-alpha reductase inhibitor that reduces the conversion of testosterone to DHT. Finasteride is FDA-approved for androgenetic alopecia in men. Response varies by individual, and it carries known risks your provider will review with you.
A vasodilator that increases blood flow to hair follicles. Topical minoxidil is FDA-approved for androgenetic alopecia in men and women; oral minoxidil is prescribed off-label for hair loss.
A copper peptide studied in research settings for its role in follicle and skin signaling. GHK-Cu is not FDA-approved for any hair indication, and its safety and effectiveness have not been established through FDA review.
An androgen receptor blocker prescribed off-label for female pattern hair loss. Spironolactone is not FDA-approved for hair loss, and response varies by individual.
Compounded medications are prepared by a licensed compounding pharmacy and are not FDA-approved products. FDA approval statements above refer only to the specific brand-name products named.
Most patients notice decreased hair fall as the treatment begins to work.
Fine, new hairs begin to emerge from previously dormant follicles.
Noticeable thickening and improved coverage in treated areas.
Full benefit of treatment is typically realized at 9–12 months.
A comprehensive evaluation by your Azul Rx provider, including a review of your health history and optional lab work, can identify the underlying cause of your hair loss and guide the most effective treatment approach.
Response varies widely by individual and by medication, and some people do not respond at all. Your provider will set expectations based on the specific medication prescribed and reassess with you over time.
It depends on the treatment and on you. Topical minoxidil is FDA-approved for women; spironolactone is used off-label for hair loss; GHK-Cu is not FDA-approved for any hair indication. Finasteride is contraindicated in women who are or may become pregnant. A provider will review which options, if any, are appropriate for you.
Hair loss treatments typically need to be maintained to sustain results. If treatment is stopped, hair loss may resume over time. Your provider will discuss long-term management strategies during your consultation.
Get a personalized hair loss treatment plan from a licensed provider — no office visit required.
Get Started